Similar articles

• [Acute monoblastic leukemia with MLL/AF9 rearrangement which developed 18 months after myeloid sarcoma onset].

  Sato Y, Nakazawa A, Kurosawa H, Fukushima K, Okuya M, Hagisawa S, Sugita K, Arisaka O. Sato Y, et al. Rinsho Ketsueki. 2013 Dec;54(12):2167-70. Rinsho Ketsueki. 2013. PMID: 24452147 Japanese.
• MLL-AF9 rearrangement in myeloid sarcomas involving the breast.

  Wu B, Li F, Zou S. Wu B, et al. Ann Hematol. 2014 Apr;93(4):709-10. doi: 10.1007/s00277-013-1850-x. Epub 2013 Jul 31. Ann Hematol. 2014. PMID: 23900528 Review. No abstract available.
• Infantile mixed phenotype acute leukemia (bilineal and biphenotypic) with t(10;11)(p12;q23);MLL-MLLT10.

  Lou Z, Zhang CC, Tirado CA, Slone T, Zheng J, Zaremba CM, Oliver D, Chen W. Lou Z, et al. Leuk Res. 2010 Aug;34(8):1107-9. doi: 10.1016/j.leukres.2010.02.029. Epub 2010 Mar 17. Leuk Res. 2010. PMID: 20299091
• ArgBP2, encoding a negative regulator of ABL, is fused to MLL in a case of infant M5 acute myeloid leukemia involving 4q35 and 11q23.

  Pession A, Lo Nigro L, Montemurro L, Serravalle S, Fazzina R, Izzi G, Nucifora G, Slany R, Tonelli R. Pession A, et al. Leukemia. 2006 Jul;20(7):1310-3. doi: 10.1038/sj.leu.2404222. Epub 2006 Apr 20. Leukemia. 2006. PMID: 16628191 No abstract available.
• MLL-MLLT10 fusion in acute monoblastic leukemia: variant complex rearrangements and 11q proximal breakpoint heterogeneity.

  Morerio C, Rapella A, Rosanda C, Lanino E, Lo Nigro L, Di Cataldo A, Maserati E, Pasquali F, Panarello C. Morerio C, et al. Cancer Genet Cytogenet. 2004 Jul 15;152(2):108-12. doi: 10.1016/j.cancergencyto.2003.11.012. Cancer Genet Cytogenet. 2004. PMID: 15262427 Review.